Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm

Stock Information for Harpoon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Harpoon Therapeutics Inc.

First Financial Northwest, Inc. Reports Third Quarter 2024 Results
First Financial Northwest, Inc. Announces Receipt of Federal Deposit Insurance Corporation Approval for Transaction with Global Credit Union
First Financial Northwest, Inc. Reports Net Income of $1.6 Million or $0.17 Per Diluted Share for the Second Quarter Ended June 30, 2024
First Financial Northwest, Inc. Announces Receipt of Shareholder Approval for Transaction with Global Credit Union
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, SBOW, FFNW, FREE on Behalf of Shareholders
URGENT ALERT: The M&A Class Action Firm Investigates Merger and Looming Vote on July 19, 2024, of First Financial Northwest, Inc. - FFNW
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, SRDX, CALB, FFNW on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FFNW, MGRC, CALB on Behalf of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.